[1]
|
Weetman AP. Thyroid-associated disease pathophysiology[J].Lancet, 1991, 338:25. |
[2]
|
Weetman AP. Gaves'disease[J]. N Engl J Med, 2000, 343:1236-1248. |
[3]
|
Anastaia P, Joanna ML,Virginia C, et al. T cells and fibroblasts in affected extraocular muscles in ealy and late thyroid associated ophthalmopathy[J]. J Br Ophthlnol, 2000, 84:517-522. |
[4]
|
Bahn RS. Understanding the immunology of Graves'ophthalmopathy. Is it an autoimmune disease?[J]. J Endocrinol Metab Clin North Am, 2000, 29(2):287-296. |
[5]
|
Tomer Y, Greenberg D, Barbesino G, et al. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production[J]. J Clin Endocrinol Metab, 2001,86:1687-1693. |
[6]
|
Weetman AP. Autoimmune thyroid disease:propagation and progress[J]. Eur J Endocrinol, 2003, 148(1):1-9. |
[7]
|
Burggasser G, Hurtl I, Hauff W, et al. Orbital scintigTaphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves'disease[J]. J Nucl Med, 2003, 44(10):1547-1555. |
[8]
|
Cascini GL, Cuccurullo V, Rambaldi PF, et al. Immunological imaging using tagged octreotide[J]. Minerva Endocrinol, 2001, 26(3):129-133. |
[9]
|
Pasquali D, Vassallo P, Esposito D, et al. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves'ophthalmopathy[J]. J Mol Endocrinol, 2000, 25(1):63-71. |
[10]
|
Gerding MN, Zant FM, Royent EA, et al. Octretide- scintigraphy is a disease activity parameter in Graves'ophthalmopathy[J]. Clin Endocrinol, 2002, 50(3):373-379. |
[11]
|
Kainz H, Bale R, Donnemiller E, et al. Image fusion analysis of 99Tcm-HYNIC-Octreotide scintigraphy and CT/MRI in patients with thyroid-associated ophthalmopathy:the importance of the lacrimal gland[J]. Eur J Nucl Med, 2003, 30:1155-1159. |
[12]
|
Doumas AS, Krassas G, Kaltsas T, et al. Imaging somatostatin receptor activity in patients with active thyroid eye disease using Tc-99m depreotide[J]. Clin Nucl Med, 2003, 28(5):439-440. |
[13]
|
Prumme MF, Gerding MN, Zonneveld FW, et al. The usefulness of quantitative orbital MRI in Graves'ophthalmopathy[J]. Clin Endocrinol, 2001, 54:205-209. |
[14]
|
Virgolini I, Tranb T, Novotny C, et al. Radiolabeled peptides in oncology[J]. Nucl Med Commun, 2000, 21:562-563. |